scholarly article | Q13442814 |
P50 | author | Suman Jayadev | Q43407273 |
Bernardino F. Ghetti | Q56863342 | ||
Thomas J Montine | Q67207389 | ||
P2093 | author name string | Thomas D Bird | |
Gerard D Schellenberg | |||
James B Leverenz | |||
Ellen J Steinbart | |||
David Nochlin | |||
James A Mastrianni | |||
Parvoneh Poorkaj | |||
P2860 | cites work | Neuropathological stageing of Alzheimer-related changes | Q27860862 |
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease | Q29614948 | ||
Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. | Q30483865 | ||
Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. | Q33575860 | ||
Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies | Q33747695 | ||
High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes | Q34146052 | ||
Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient | Q37209166 | ||
Coexistence of Creutzfeldt-Jakob disease, Lewy body disease, and Alzheimer's disease pathology: an autopsy case showing typical clinical features of Creutzfeldt-Jakob disease | Q37247810 | ||
Familial Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles | Q40625739 | ||
A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V. | Q43510340 | ||
A sporadic case of Creutzfeldt-Jakob disease with beta-amyloid deposits and alpha-synuclein inclusions | Q48098461 | ||
A68 is a component of paired helical filaments of Gerstmann-Sträussler-Scheinker disease, Indiana kindred | Q48249450 | ||
Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. | Q52215816 | ||
Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. | Q53186541 | ||
Allelic origin of the abnormal prion protein isoform in familial prion diseases | Q59690434 | ||
Diagnosis of Gerstmann-Sträussler syndrome in familial dementia with prion protein gene analysis | Q69371156 | ||
Gerstmann-Sträussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family | Q69375844 | ||
Gerstmann-Sträussler-Scheinker disease (PRNP P102L): amyloid deposits are best recognized by antibodies directed to epitopes in PrP region 90-165 | Q71832807 | ||
Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele | Q93870994 | ||
P433 | issue | 4 | |
P921 | main subject | Alzheimer's disease | Q11081 |
prion protein family | Q24724413 | ||
P304 | page(s) | 712-720 | |
P577 | publication date | 2011-03-17 | |
P1433 | published in | Annals of Neurology | Q564414 |
P1476 | title | Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype | |
P478 | volume | 69 |
Q33881345 | 11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer's disease in the absence of known mutations retains higher levels of PIB in the basal ganglia |
Q38333529 | A new prion disease: relationship with central and peripheral amyloidoses |
Q84522846 | A novel mutation I215V in the PRNP gene associated with Creutzfeldt-Jakob and Alzheimer's diseases in three patients with divergent clinical phenotypes |
Q37393739 | A novel prion disease associated with diarrhea and autonomic neuropathy |
Q37377977 | Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology |
Q60309357 | Amyloid- and tau-PET imaging in a familial prion kindred |
Q26765999 | Beta-Amyloid and Tau-Protein: Structure, Interaction, and Prion-Like Properties |
Q42007280 | Burial of the polymorphic residue 129 in amyloid fibrils of prion stop mutants |
Q48000756 | C-Terminal-Deleted Prion Protein Fragment Is a Major Accumulated Component of Systemic PrP Deposits in Hereditary Prion Disease With a 2-Bp (CT) Deletion in PRNP Codon 178. |
Q58781975 | Characterization of mutations in (prion) gene and their possible roles in neurodegenerative diseases |
Q33761828 | Complex proteinopathy with accumulations of prion protein, hyperphosphorylated tau, α-synuclein and ubiquitin in experimental bovine spongiform encephalopathy of monkeys |
Q41893320 | Conserved amyloid core structure of stop mutants of the human prion protein |
Q37522591 | Distinct patterns of spread of prion infection in brains of mice expressing anchorless or anchored forms of prion protein |
Q37053839 | Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders |
Q92603855 | Early-onset Alzheimer's disease patient with prion (PRNP) p.Val180Ile mutation |
Q95933928 | Evaluating drug targets through human loss-of-function genetic variation |
Q46560834 | Genetic PrP Prion Diseases |
Q37491711 | Genetic Prion Disease Caused by PRNP Q160X Mutation Presenting with an Orbitofrontal Syndrome, Cyclic Diarrhea, and Peripheral Neuropathy |
Q53396036 | Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project. |
Q39036368 | Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature. |
Q56069696 | Genetics of dementia |
Q38027808 | Genetics of dementia: update and guidelines for the clinician |
Q38091816 | Genetics of prion diseases |
Q37596331 | Gerstmann-Sträussler-Scheinker disease and "anchorless prion protein" mice share prion conformational properties diverging from sporadic Creutzfeldt-Jakob disease |
Q38871224 | Hereditary Human Prion Diseases: an Update |
Q37969262 | Interaction between pathogenic proteins in neurodegenerative disorders |
Q38600851 | Lavandula angustifolia extract improves deteriorated synaptic plasticity in an animal model of Alzheimer's disease |
Q34576746 | Levels of the Mahogunin Ring Finger 1 E3 ubiquitin ligase do not influence prion disease |
Q26750717 | Molecular genetics of early-onset Alzheimer's disease revisited |
Q37464666 | Mutational analysis of PRNP in Alzheimer's disease and frontotemporal dementia in China |
Q36218610 | New approaches to genetic counseling and testing for Alzheimer's disease and frontotemporal degeneration |
Q34222296 | Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations |
Q34244138 | Nonsense mutation in PRNP associated with clinical Alzheimer's disease |
Q49957320 | Prion Proteins Without the Glycophosphatidylinositol Anchor: Potential Biomarkers in Neurodegenerative Diseases |
Q34488612 | Proteomics analysis of amyloid and nonamyloid prion disease phenotypes reveals both common and divergent mechanisms of neuropathogenesis |
Q36639581 | Quantifying prion disease penetrance using large population control cohorts |
Q38089232 | Review: cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy |
Q37058503 | Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessons |
Q35784863 | Squirrel monkeys (Saimiri sciureus) infected with the agent of bovine spongiform encephalopathy develop tau pathology |
Q37989099 | The contribution of different prion protein types and host polymorphisms to clinicopathological variations in Creutzfeldt-Jakob disease |
Q38623320 | The pathogenesis of soluble PrP fragments containing Aβ binding sites |
Q55285207 | Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis. |
Q37485590 | Unusual cerebral vascular prion protein amyloid distribution in scrapie-infected transgenic mice expressing anchorless prion protein |
Search more.